Table 2 Adjuvant therapy.

From: Retrospective Analysis of Radiological Recurrence Patterns in Glioblastoma, Their Prognostic Value And Association to Postoperative Infarct Volume

Initial adjuvant therapy

- Stupp scheme

96/129 (74.4%)

- only chemotherapy

8/129 (6.2%)

- only radiotherapy

24/129 (18.6%)

- bevacizumab

4/129 (3.1%)

- Chlorethyl-Cyclohexyl-Nitroso-Urea (CCNU)

3/129 (2.3%)

Therapy after first recurrence

- surgery

56/129 (43.4%)

- chemotherapy

80/129 (62.0%)

- radiotherapy

47/129 (36.4%)

- bevacizumab

26/129 (20.2%)

- CCNU

13/129 (10.1%)